Gary R. Maharaj - 01 Apr 2022 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
President & CEO, Director
Signature
/s/ John Manders on behalf of Gary R. Maharaj
Issuer symbol
SRDX
Transactions as of
01 Apr 2022
Net transactions value
-$179,954
Form type
4
Filing time
05 Apr 2022, 17:31:09 UTC
Previous filing
02 Dec 2021
Next filing
29 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Sale $175,399 -3,900 -2.5% $44.97 155,141 01 Apr 2022 Direct F1, F2, F3
transaction SRDX Common Stock Sale $4,555 -100 -0.06% $45.55 155,041 01 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 30, 2021.
F2 Reflects the weighted average price of 3,900 shares of common stock of Surmodics, Inc. sold by the reporting person in multiple transactions on April 1, 2022 with sale prices ranging from $44.49 to $45.45 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3 Includes 308 shares acquired through the Employee Stock Purchase Plan for the phase ending 2/28/22.